← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2005Last known activity
Aug 22, 2022
Timeline
2000s
- Jan 1, 2000
MediciNova— Founded
- Jan 1, 2009
Avigen— Acquired
Drugs by trial phase (8 distinct, 27 trials)
Phase 3 (0 own, 1 via acquisition)
Phase 2 (3 own, 2 via acquisition)
Phase 1 (0 own, 2 via acquisition)
Indications
Studied for
- Alcohol Drinking
- Alcoholism
- Amyotrophic Lateral Sclerosis
- Asthma
- Cystitis
- Cystitis, Interstitial
- Fatty Liver
- Fibrosis
- Glioblastoma
- Hypercholesterolemia
- Hypertriglyceridemia
- Idiopathic Pulmonary Fibrosis
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Motor Neuron Disease
- Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
- Non-alcoholic Fatty Liver Disease
- Opioid-Related Disorders
- Pneumonia
- Pneumonia, Viral
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Fibrosis
- Sclerosis
- Status Asthmaticus
- Substance-Related Disorders
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (29)
- NCT06743776CollaboratorN/A—
- NCT05464784Lead sponsorPhase 2Aug 22, 2022
- NCT04429555Study chairPhase 2Jul 31, 2020
- NCT04429555Lead sponsorPhase 2Jul 31, 2020
- NCT04057898Lead sponsorPhase 2/Phase 3Oct 31, 2019
- NCT04054206Lead sponsorPhase 1Jun 24, 2019
- NCT03782415Lead sponsorPhase 1/Phase 2Dec 29, 2018
- NCT03594435CollaboratorPhase 2Sep 30, 2018
- NCT03533387Lead sponsorPhase 1Apr 11, 2018
- NCT02503657Study chairPhase 2Mar 1, 2016
- NCT02714036Lead sponsorPhase 1/Phase 2Mar 1, 2016
- NCT02681055Lead sponsorPhase 2Mar 1, 2016
- NCT02503657Lead sponsorPhase 2Mar 1, 2016
- NCT02681055Study directorPhase 2Mar 1, 2016
- NCT02238626Lead sponsorPhase 2Sep 1, 2014
Details
- Founded
- San Diego, CA, US Jan 1, 2000
- Last known activity
- Aug 22, 2022